Moderator:
• Mr Sandeep Amritkar, Assistant Director, Lupin Pharmaceuticals
Panelists in this video:
• Dr Amarender Reddy Donthidi, VP & Head – R&D Injectables and Ophthalmics, Amneal Pharmaceuticals
• Mr Mayurbhai Sankalia, VP – Research & Development, Invengene
• Dr Ramesh Nagarwal, VP Complex Injectable, BDR Pharma
• Mr Rakesh Kumar Sinha, VP & Head – Drug Product Manufacturing, Biological E
• Mr Loganathan S, AVP, Onesource Biopharma
• Dr Khalid Akhter Ansari, Senior Director, Rising Pharmaceuticals
Key Highlights:
[1] Injectables are moving towards painless, precise delivery systems, enhancing patient-centricity
[2] Long-acting and extended-release formulations are reducing injection frequency, improving patient adherence, and improving therapeutic outcomes
[3] Design of injectables is a critical differentiator. Now, injectable delivery systems need to be intuitive, ergonomic, offer precise and targeted delivery, uphold therapeutic intent, and improve patient-centricity
[4] We must innovate to make complex injectable therapies more cost-effective and accessible, without compromising on quality or efficacy
[5] When designing an injectable product, it’s essential to design with manufacturing in mindto ensure scalability and cost-efficiency
[6] Smart injectables and connected autoinjectors are improving real-time monitoring, data sharing and personalised dosing
[7] Whether it’s green needles, autoinjectors, or interconnected injectable systems, innovation is being driven by the need for sustainability, ease of use, improved efficacy, and enhanced patient experience